# Effects of beta-alanine supplementation and high-intensity interval training on endurance performance and body composition in men; a double-blind trial

PMID: 19210788
Journal: Journal of the International Society of Sports Nutrition
Published: 2009 Feb 11
Authors: Smith AE, Walter AA, Graef JL, Kendall KL, Moon JR, Lockwood CM, Fukuda DH, Beck TW, Cramer JT, Stout JR

## Question

Does beta-alanine supplementation enhance the endurance-performance and body-composition adaptations to six weeks of cycling HIIT in recreationally active college-aged men?

## Summary

In recreationally active young men, six weeks of supervised cycling HIIT improved aerobic performance and total work. Beta-alanine appeared to add benefit in the second half of training for VO2peak, time to exhaustion, total work, and lean body mass, but the evidence mixes HIIT with a sports supplement.

## Population

- Recreationally active college-aged men
- Sample size: 46
- Age: 22.2 +/- 2.7 years
- Sex: Male
- Fitness level: Recreationally active 1-5 hours/week
- Health status: No recent sports supplement use; otherwise not fully specified

## Methodology

- Double-blind randomized supplementation trial with HIIT in both groups
- 6 weeks
- University laboratory cycle ergometer training and testing
- Randomized and controlled study design.

## Protocol

- Cycling HIIT plus beta-alanine.
- Modality: Cycle ergometer.
- Work intervals: 2 minutes.
- Recovery: 1 minute rest.
- Sets or repetitions: 5-6 bouts.
- Intensity: 90-115% of VO2peak power output.
- Session duration: About 19-23 minutes plus any setup.
- Frequency: 3 days/week.
- Program length: 6 weeks.
- Progression: Intensity and repetitions progressed across the two 3-week phases.
- Cycling HIIT plus placebo.
- Modality: Cycle ergometer.
- Work intervals: 2 minutes.
- Recovery: 1 minute rest.
- Sets or repetitions: 5-6 bouts.
- Intensity: 90-115% of VO2peak power output.
- Session duration: About 19-23 minutes plus any setup.
- Frequency: 3 days/week.
- Program length: 6 weeks.
- Progression: Same as beta-alanine group.

## Outcomes

### VO2peak
Status: improved
Both groups improved by mid-test; only beta-alanine improved significantly from mid to post.

Pre-to-mid p<0.001; beta-alanine mid-to-post p=0.010; placebo p=0.118

### time to exhaustion
Status: improved
Both groups improved by mid-test; only beta-alanine had a significant mid-to-post improvement.

Pre-to-mid p<0.001; beta-alanine mid-to-post p=0.043

### total work
Status: improved
Total work improved over all time points in both groups, without significant between-group differences.

Time effect p>0.05 between groups; ES 0.898

### body composition
Status: mixed
Lean body mass increased in beta-alanine only; weight, body fat percentage, and fat mass did not significantly change.

Lean body mass in beta-alanine p=0.011

## Practical Insights

- A 5-6 x 2-minute cycling interval format is a useful endurance-building template.
- Failure-tolerant interval rules are useful: if a hard rep cannot be completed, recover and attempt the next bout.
- Supplement findings should remain outside workout-generation logic unless nutrition features are in scope.

## Limitations

- Men only
- No HIIT-free control
- Supplement co-intervention
- No clear adverse-event reporting
- Lab cycle ergometer protocol

## Safety And Adherence

- The article did not report adverse events, injuries, or symptoms during beta-alanine/placebo plus HIIT.
- Participants were informed of potential risks before consent; training was supervised, heart rate was monitored during testing, and training logs were completed for each session.
- Supplement and training compliance did not differ significantly between groups, but the paper did not provide an exact attendance or dropout rate for the randomized sample.

## Original Sources

- [PubMed](https://pubmed.ncbi.nlm.nih.gov/19210788/) (pubmed)
- [DOI](https://doi.org/10.1186/1550-2783-6-5) (doi)
- [PMC full text](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2649036/) (full text)

## Agent Guidance

Preserve the paper-level scope of this note. Do not generalize beyond the population, protocol, measured outcomes, and limitations above.